Document:

ex10_1.htm

    
      
        

      

    

    Exhibit
      10.1

    

    CORCEPT
      THERAPEUTICS INCORPORATED

    

    COMMON
      STOCK PURCHASE AGREEMENT

     

    This
      Common Stock Purchase Agreement (“Agreement”) is made as of August 16,
      2007 (the “Effective Date”), by and among Corcept Therapeutics
      Incorporated, a Delaware corporation (the “Company”), and each of those
      persons and entities, severally and not jointly, listed as a Purchaser on the
      Schedule of Purchasers attached as Exhibit A hereto (the “Schedule of
      Purchasers”).  Such persons and entities are
      hereinafter collectively referred to herein as “Purchasers” and each
      individually as a “Purchaser”.

     

    AGREEMENT

     

    In
      consideration of the mutual covenants contained in this Agreement, and for
      other
      good and valuable consideration, the receipt of which is hereby acknowledged,
      the Company and each Purchaser (severally and not jointly) hereby agree as
      follows:

     

    SECTION
      1.  AUTHORIZATION OF SALE OF SHARES.

     

    The
      Company has authorized the sale and issuance of 4,790,473 shares of its Common
      Stock, par value $0.001 per share (the “Common Stock”), on the terms and
      subject to the conditions set forth in this Agreement.  The shares of
      Common Stock sold hereunder at the Initial Closing (as defined below) shall
      be
      referred to as the “Initial Shares”; the shares of Common Stock sold
      hereunder at the Second Closing (as defined below) shall be referred to as
      the
“Second Closing Shares”; and the Initial Shares and the Second Closing
      Shares together shall be referred to herein as the “Shares”.

     

    SECTION
      2.  AGREEMENT TO SELL AND PURCHASE THE SHARES.

     

    2.1           Sale
      of Shares.  At the Closing (as defined in Section 3), the
      Company will sell to each Purchaser, and each Purchaser will purchase from
      the
      Company, at a purchase price of $2.10 per Share, the number of Shares set forth
      next to such Purchaser’s name on the Schedule of Purchasers.

     

    2.2           Separate
      Agreement.  Each Purchaser shall severally, and not jointly,
      be liable for only the purchase of the Shares that appear on Exhibit A
      hereto and that relate to such Purchaser.  The Company’s agreement
      with each of the Purchasers is a separate agreement, and the sale of Shares
      to
      each of the Purchasers is a separate sale.  The obligations of each
      Purchaser hereunder are expressly not conditioned on the purchase by any or
      all
      of the other Purchasers of the Shares such other Purchasers have agreed to
      purchase.

     

    SECTION
      3.  CLOSING AND DELIVERY.

     

    3.1           Initial
      Closing.  The closing of the purchase and sale of the Initial
      Shares (which Shares are set forth in the Schedule of Purchasers) pursuant
      to
      this Agreement (the “Initial Closing”) shall be held on August 17, 2007
      at the offices of Latham & Watkins LLP, 140 Scott Drive, Menlo Park,
      California 94025, or on such other date and place as may be agreed to by the
      Company and the Purchasers.  At or prior to the Initial Closing, each
      Purchaser shall execute any related agreements or other documents required
      to be
      executed hereunder, dated as of the date of the Initial Closing (the “Initial
      Closing Date”).

     

    
      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

    3.2           Second
      Closing.  The closing of the purchase and sale of the Second
      Closing Shares (which Shares are set forth in the Schedule of Purchasers)
      pursuant to this Agreement (the “Second Closing”, the Initial Closing and
      the Second Closing together are referred to herein as the “Closings” and
      each is referred to herein as a “Closing”) shall be held on the second
      business day immediately following satisfaction of the conditions to the Second
      Closing set forth in Sections 6 and 7 of the Agreement at the offices of Latham
      & Watkins LLP, 140 Scott Drive, Menlo Park, California 94025, or on such
      other date and place as may be agreed to by the Company and the Purchasers
      who
      will purchase Second Closing Shares (the “Second Closing
      Purchasers”).  At or prior to the Second Closing, each Second
      Closing Purchaser shall execute any related agreements or other documents
      required to be executed hereunder in connection with the Second Closing, dated
      as of the date of the Second Closing (the “Second Closing Date”).
      Notwithstanding the foregoing, in no event shall the Second Closing occur
      earlier than 30 days after the Initial Closing Date.

     

    3.3           Delivery
      of the Shares at each Closing.  At each Closing, the Company
      shall deliver to each Purchaser stock certificates registered in the name of
      such Purchaser, or in such nominee name(s) as designated by such Purchaser,
      representing the number of shares of Common Stock to be purchased by such
      Purchaser at such Closing as set forth in the Schedule of Purchasers against
      payment of the purchase price for such Shares.  The name(s) in which
      the stock certificates are to be issued to each Purchaser are set forth in
      the
      Investor Questionnaire and the Selling Stockholder Notice and Questionnaire
      in
      the form attached hereto as Appendix I and II (the “Investor
      Questionnaire” and the “Selling Stockholder Questionnaire”,
      respectively), as completed by each Purchaser, which shall be provided to the
      Company no later than the Initial Closing Date.

     

    SECTION
      4.  REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
      COMPANY.

     

    Except
      as
      set forth on the Schedule of Exceptions delivered to the Purchasers concurrently
      with the execution of this Agreement (the “Schedule of Exceptions”), the
      Company hereby represents and warrants as of the date hereof to, and covenants
      with, the Purchasers as follows:

     

    4.1           Organization
      and Standing.  The Company has been duly incorporated and is
      validly existing as a corporation in good standing under the laws of Delaware,
      has full corporate power and authority to own or lease its properties and
      conduct its business as presently conducted, and is duly qualified as a foreign
      corporation and in good standing in all jurisdictions in which the character
      of
      the property owned or leased or the nature of the business transacted by it
      makes qualification necessary, except where the failure to be so qualified
      would
      not have a material adverse effect on the business, properties, financial
      condition or results or operations of the Company (a “Company Material
      Adverse Effect”).  The Company has no subsidiaries or equity
      interest in any other entity.

     

    
      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

    

    

    4.2           Corporate
      Power; Authorization.  The Company has all requisite
      corporate power, and has taken all requisite corporate action, to execute and
      deliver this Agreement, sell and issue the Shares and carry out and perform
      all
      of its obligations under this Agreement, except with respect to the Stockholder
      Approval (as defined below).  This Agreement constitutes the legal,
      valid and binding obligation of the Company, enforceable in accordance with
      its
      terms, except (i) as limited by applicable bankruptcy, insolvency,
      reorganization, moratorium or similar laws relating to or affecting the
      enforcement of creditors’ rights generally, (ii) as limited by equitable
      principles generally, including any specific performance, and (iii) as to those
      provisions of Section 8.3 relating to indemnity or contribution.  The
      execution and delivery of this Agreement does not, and the performance of this
      Agreement and the compliance with the provisions hereof and the issuance, sale
      and delivery of the Shares by the Company will not conflict with, or result
      in a
      breach or violation of the terms, conditions or provisions of, or constitute
      a
      default under, or result in the creation or imposition of any lien pursuant
      to
      the terms of, the Certificate of Incorporation or Bylaws of the Company or
      any
      statute, law, rule (including federal and state securities laws and the rules
      and regulations of the NASDAQ Capital Market (the “Principal Market”))
      applicable to the Company or regulation or any state or federal order, judgment
      or decree applicable to the Company or any indenture, mortgage, lease or other
      material agreement or instrument to which the Company is a party or any of
      its
      properties is subject.

     

    4.3           Issuance
      and Delivery of the Shares.  The Shares, when issued and paid
      for in compliance with the provisions of this Agreement, will be validly issued,
      fully paid and nonassessable.  The issuance and delivery of the Shares
      is not subject to preemptive, co-sale, right of first refusal or any other
      similar rights of the stockholders of the Company or any liens or
      encumbrances.  Assuming the accuracy of the representations made by
      each Purchaser in Section 5, the offer and issuance by the Company of the Shares
      is exempt from registration under the 1933 Act.

     

    4.4           SEC
      Documents; Financial Statements.  The Company has filed in a
      timely manner all documents that the Company was required to file with the
      Securities and Exchange Commission (the “Commission”) under Sections 13,
      14(a) and 15(d) the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), since becoming subject to the requirements of the
      Exchange Act.  As of their respective filing dates (or, if amended
      prior to the date of this Agreement, when amended), all documents filed by
      the
      Company with the Commission (the “SEC Documents”) complied in all
      material respects with the requirements of the Exchange Act and the rules and
      regulations of the Commission promulgated thereunder.  None of the SEC
      Documents as of their respective dates contained any untrue statement of
      material fact or omitted to state a material fact required to be stated therein
      or necessary to make the statements made therein, in light of the circumstances
      under which they were made, not misleading.  The financial statements
      of the Company included in the SEC Documents (the “Financial Statements”)
      comply as to form in all material respects with applicable accounting
      requirements and with the published rules and regulations of the Commission
      with
      respect thereto.  The Financial Statements have been prepared in
      accordance with United States generally accepted accounting principles
      consistently applied and fairly present the financial position of the Company
      at
      the dates thereof and the results of its operations and cash flows for the
      periods then ended (subject, in the case of unaudited statements, to normal,
      recurring adjustments).

     

    
      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

    

    

    4.5           Capitalization.  All
      of the Company’s outstanding shares of capital stock have been duly authorized
      and validly issued and are fully paid and nonassessable, have been issued in
      compliance with all federal and state securities laws, and were not issued
      in
      violation of or subject to any preemptive right or other rights to subscribe
      for
      or purchase securities.  The authorized capital stock of the Company
      consists of 140,000,000 shares of common stock and 10,000,000 shares of
      undesignated Preferred Stock, none of which are issued and outstanding as of
      the
      Effective Date.  As of the Effective Date, there are 34,756,766 shares
      of Common Stock issued and outstanding, of which no shares are owned by the
      Company.  There are no other shares of any other class or series of
      capital stock of the Company issued or outstanding.  The Company has
      no capital stock reserved for issuance, except that, as of the Effective Date,
      there are 3,667,186 shares of Common Stock reserved for
      issuance pursuant to options outstanding on such date pursuant to the Company’s
      2000 Stock Option Plan and 2004 Equity Incentive Plan.  There are no
      bonds, debentures, notes or other indebtedness having general voting rights
      (or
      convertible into securities having such rights) (“Voting Debt”) of the
      Company issued and outstanding.  Except as stated above, there are no
      existing options, warrants, calls, subscriptions or other rights, agreements,
      arrangements or commitments of any character, relating to the issued or unissued
      capital stock of the Company, obligating the Company to issue, transfer, sell,
      redeem, purchase, repurchase or otherwise acquire or cause to be issued,
      transferred, sold, redeemed, purchased, repurchased or otherwise acquired any
      capital stock or Voting Debt of, or other equity interest in, the Company or
      securities or rights convertible into or exchangeable for such shares or equity
      interests or obligations of the Company to grant, extend or enter into any
      such
      option, warrant, call, subscription or other right, agreement, arrangement
      or
      commitment.  The issuance of Common Stock or other securities pursuant to
      any provision of this Agreement will not give rise to any preemptive rights
      or
      rights of first refusal on behalf of any Person or result in the triggering
      of
      any anti-dilution or other similar rights.  Except as disclosed in the
      SEC Documents, there are no agreements or arrangements under which the Company
      or any of its Subsidiaries is obligated to register the sale of any of their
      securities under the 1933 Act.  There are no securities or instruments
      containing anti-dilution provisions that will be triggered by the issuance
      of
      the Shares.  The Company has made available upon request of the
      Purchasers, a true, correct and complete copy of the Company’s Certificate of
      Incorporation, as amended and as in effect on the date hereof (the
“Certificate of Incorporation”), and the Company’s Bylaws, as amended and
      as in effect on the date hereof (the “Bylaws”).

     

    4.6           Litigation.  There
      is no pending or, to the Company’s knowledge, threatened, action, suit or other
      proceeding to which the Company is a party or to which its property or assets
      are subject.

     

    4.7           Governmental
      Consents. No consent, approval, order or authorization of, or
      registration, qualification, designation, declaration or filing with, any
      federal, state, or local governmental authority on the part of the Company
      is
      required in connection with the consummation of the transactions contemplated
      by
      this Agreement except for (a) the filing of a Form D with the Commission under
      the 1933 Act and compliance with the securities and blue sky laws in the states
      and other jurisdictions in which shares of Common Stock are offered and/or
      sold,
      which compliance will be effected in accordance with such laws, (b) the approval
      by the Principal Market of the listing of the Shares, (c) such filings and
      approvals as are required in connection with the Stockholder Approval, and
      (d)
      the filing of a registration statement and all amendments thereto with the
      Commission as contemplated by Section 8.1 of this Agreement.

     

    
      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

    

    

    4.8           No
      Material Adverse Change.  Since June 30, 2007, except as
      disclosed in the SEC Documents, there have not been any changes in the assets,
      liabilities, financial condition or operations of the Company from that
      reflected in the Financial Statements for the quarter ended June 30, 2007 except
      changes which have not had, either individually or in the aggregate, a Company
      Material Adverse Effect.

     

    4.9           No
      General Solicitation.  Neither the Company, nor any of its
      affiliates, nor any Person acting on its or their behalf, has engaged in any
      form of general solicitation or general advertising (within the meaning of
      Regulation D promulgated under the Securities Act of 1933, as amended (the
      “Securities Act”)) in connection with the offer or sale of the Shares.

     

    4.10         No
      Integrated Offering.  None of the Company, its Subsidiaries,
      any of their affiliates, or any Person acting on their behalf has, directly
      or
      indirectly, made any offers or sales of any security or solicited any offers
      to
      buy any security, under circumstances that would require registration of any
      of
      the Shares under the 1933 Act or cause this offering of the Shares to be
      integrated with prior offerings by the Company for purposes of the 1933 Act
      or
      any applicable stockholder approval provisions, including, without limitation,
      under the rules and regulations of the Principal Market.

     

    4.11         Sarbanes-Oxley
      Act.  To the knowledge of the executive officers of the
      Company, the Company is in material compliance with the requirements of the
      Sarbanes-Oxley Act of 2002 that are effective and applicable to the Company
      as
      of the date hereof, and the rules and regulations promulgated by the SEC
      thereunder that are effective and applicable to the Company as of the date
      hereof.

     

    4.12         Patents
      and Trademarks.  To the knowledge of the executive officers
      of the Company, the Company and the Subsidiaries have, or have rights to use,
      all patents, patent applications, trademarks, trademark applications, service
      marks, trade names, copyrights, licenses and other similar rights that are
      necessary or material for use in connection with their respective businesses
      as
      described in the SEC Documents and which the failure to so have could,
      individually or in the aggregate, have or reasonably be expected to result
      in a
      Material Adverse Effect (collectively, the “Intellectual Property
      Rights”).  Except as set forth in the SEC Documents, neither the
      Company nor any Subsidiary has received a written notice that the Intellectual
      Property Rights used by the Company or any Subsidiary violates or infringes
      upon
      the rights of any Person.  Except as set forth in the SEC Documents, to the
      knowledge of the executive officers of the Company, all such Intellectual
      Property Rights are enforceable and there is no existing infringement by another
      Person of any of the Intellectual Property Rights.

     

    4.13         Listing
      and Maintenance Requirements.  Except as specified in the SEC
      Documents and the Schedule of Exceptions, the Company has not, in the two years
      preceding the date hereof, received notice from the Principal Market to the
      effect that the Company is not in compliance with the listing or maintenance
      requirements thereof.   Except as disclosed in the SEC Documents
      and the Schedule of Exceptions, the Company is in compliance with the listing
      and maintenance requirements for continued listing of the Common
      Stock.  The issuance and sale of the Initial Shares under this
      Agreement does not contravene the rules and regulations of the Principal Market
      and no approval of the stockholders of the Company thereunder is required for
      the Company to issue and deliver to the Purchasers the Initial
      Shares.  The issuance and sale of the Second Closing Shares requires
      the Stockholder Approval pursuant to the rules and regulations of the Principal
      Market.

     

    
      
        
          
          

        

        
          5

          
            

          

        

        
          
          

        

      

    

    

    4.14         Disclosure.  The
      Company understands and confirms that the Purchasers will rely on the foregoing
      representations and covenants in effecting transactions in securities of the
      Company.  To the knowledge of the executive officers of the Company, all
      due diligence materials regarding the Company, its business and the transactions
      contemplated hereby, furnished by or on behalf of the Company to the Purchasers
      upon their request are, when taken together with the SEC Documents, true and
      correct in all material respects and do not contain any untrue statement of
      a
      material fact or omit to state any material fact necessary in order to make
      the
      statements made therein, in light of the circumstances under which they were
      made, not misleading.

     

    4.15         Stockholder
      Approval.  The Company covenants and agrees that it will use
      its commercially reasonable efforts to obtain, as soon as practicable, the
      approval of its stockholders of the transactions contemplated by this Agreement
      as required by the rules and regulations of the Principal Market applicable
      to
      the Company in order to issue the Second Closing Shares, including approval
      of
      any potential change of control of the Company which may occur as a result
      of
      the sale of the Second Closing Shares (the “Stockholder
      Approval”).  In furtherance of its obligations to obtain the
      Stockholder Approval under this Section 4.15, the Company shall (a) file any
      required proxy materials with the Principal Market and the Commission as
      promptly as practicable following the Initial Closing Date, but in any event
      within 20 business days following the Initial Closing Date and respond as
      promptly as practicable to any comments from the Commission or Principal Market
      with respect thereto, (c) deliver proxy materials to its stockholders in
      furtherance thereof as promptly as practicable thereafter, (d) solicit proxies
      from its stockholders in connection therewith in the same manner as all other
      management proposals in such proxy statement, and (e) hold a meeting of the
      stockholders related thereto as promptly as practicable, but in any event not
      later than the 60th day after
      mailing
      of the definitive proxy materials to stockholders.  In the event the
      Company does not obtain the Stockholder Approval at the first meeting of its
      stockholders called for such purpose, the Company shall use commercially
      reasonable efforts to obtain the Stockholder Approval at each successive
      stockholders meeting until the Stockholder Approval is obtained.  The
      parties hereto understand that no votes may be cast in respect of any Shares
      issued and sold pursuant to this Agreement on any proposal to obtain Stockholder
      Approval pursuant hereto.

     

    SECTION
      5.  REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
      PURCHASERS.

     

    5.1           Each
      Purchaser, severally and not jointly, represents and warrants to and covenants
      with the Company that:

     

    (a)           Purchaser,
      taking into account the personnel and resources it can practically bring to
      bear
      on the purchase of the Shares contemplated hereby, is knowledgeable,
      sophisticated and experienced in making, and is qualified to make, decisions
      with respect to investments in shares presenting an investment decision like
      that involved in the purchase of the Shares, including investments in securities
      issued by the Company, and has requested, received, reviewed and considered
      all
      information Purchaser deems relevant (including the SEC Documents) in making
      an
      informed decision to purchase the Shares.

     

    
      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

    

    

    (b)           Purchaser
      is acquiring the Shares pursuant to this Agreement in the ordinary course of
      its
      business and for its own account for investment only and with no present
      intention of distributing any of such Shares or any arrangement or understanding
      with any other persons regarding the distribution of such Shares, except in
      compliance with Section 5.1(c).

     

    (c)           Purchaser
      will not, directly or indirectly, offer, sell, pledge, transfer or otherwise
      dispose of (or solicit any offers to buy, purchase or otherwise acquire or
      take
      a pledge of) any of the securities purchased hereunder except in compliance
      with
      the Securities Act, applicable blue sky laws, and the rules and regulations
      promulgated thereunder.

     

    (d)           Purchaser
      has, in connection with its decision to purchase the Shares, relied with respect
      to the Company and its affairs solely upon the SEC Documents and the
      representations and warranties of the Company contained herein.

     

    (e)           Purchaser
      is an “accredited investor” within the meaning of Rule 501 of Regulation D
      promulgated under the Securities Act or a Qualified Institutional Buyer within
      the meaning of Rule 144A promulgated under the Securities Act.

     

    (f)           Purchaser
      has full right, power, authority and capacity to enter into this Agreement
      and
      to consummate the transactions contemplated hereby and has taken all necessary
      action to authorize the execution, delivery and performance of this
      Agreement.  Upon the execution and delivery of this Agreement by
      Purchaser, this Agreement shall constitute a valid and binding obligation of
      Purchaser, enforceable in accordance with its terms, except (i) as limited
      by
      applicable bankruptcy, insolvency, reorganization, moratorium or similar laws
      relating to or affecting the enforcement of creditors’ rights generally, (ii) as
      limited by equitable principles generally, including any specific performance,
      and (iii) as to those provisions of Section 8.3 relating to indemnity or
      contribution.

     

    (g)           Purchaser
      is not a broker or dealer registered pursuant to Section 15 of the
      Securities Exchange Act of 1934 (a “registered broker-dealer”) and is not
      affiliated with a registered broker dealer.  Purchaser is not party to
      any agreement for distribution of the Shares.

     

    (h)           The
      Purchaser shall have completed or caused to be completed and delivered to the
      Company at no later than the Initial Closing Date, the Investor Questionnaire
      and the Selling Stockholder Questionnaire for use in preparation of the
      Registration Statement, and the answers to the Questionnaires are true and
      correct in all material respects as of the date of this Agreement and will
      be
      true and correct as of the Initial Closing Date, the Second Closing Date (but
      only with respect to Purchasers purchasing Shares on the Second Closing Date)
      and the effective date of the Registration Statement; provided that the
      Purchasers shall be entitled to update such information by providing notice
      thereof to the Company before the effective date of such Registration
      Statement.

     

    5.2           Purchaser
      represents, warrants and covenants to the Company that Purchaser has not, either
      directly or indirectly through an affiliate, agent or representative of the
      Company, engaged in any transaction in the Securities of the Company subsequent
      to March 30, 2007.  Purchaser represents and warrants to and covenants
      with the Company that Purchaser has not engaged and will not engage in any
      short
      sales of the Company’s Common Stock prior to the effectiveness of the
      Registration Statement (either directly or indirectly through an affiliate,
      agent or representative).

     

    
      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

    

    

    5.3           Purchaser
      understands that nothing in this Agreement or any other materials presented
      to
      Purchaser in connection with the purchase and sale of the Shares constitutes
      legal, tax or investment advice.  Purchaser has consulted such legal,
      tax and investment advisors as it, in its sole discretion, has deemed necessary
      or appropriate in connection with its purchase of the Shares.

     

    5.4           Legends.  It
      is understood that the Shares may bear one or more legends in substantially
      the
      following form and substance:

     

    “THE
      SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
      ACT
      OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAW, AND MAY NOT BE OFFERED, SOLD,
      TRANSFERRED, ENCUMBERED OR OTHERWISE DISPOSED OF EXCEPT UPON SATISFACTION OF
      CERTAIN CONDITIONS, WHICH ARE SET FORTH IN THAT CERTAIN COMMON STOCK PURCHASE
      AGREEMENT DATED AUGUST 16, 2007, WHICH ALSO CONTAINS VARIOUS OTHER PROVISIONS
      AFFECTING THESE SECURITIES, BINDING UPON TRANSFEREES
      HEREOF.  INFORMATION CONCERNING THESE RESTRICTIONS AND PROVISIONS MAY
      BE OBTAINED FROM THE CORPORATION OR ITS LEGAL COUNSEL.”

     

    In
      addition stock certificates representing the Shares may contain:

     

    (a)           Any
      legend required by the laws of the State of California, including any legend
      required by the California Department of Corporations.

     

    (b)           Any
      legend required by the blue sky laws of any other state to the extent such
      laws
      are applicable to the sale of the Shares hereunder.

     

    5.5           Restricted
      Securities.  Purchaser understands that the Shares are
      characterized as “restricted securities” under the federal securities laws
      inasmuch as they are being acquired from the Company in a transaction not
      involving a public offering and that under such laws and applicable regulations
      such Shares may be resold without registration under the Securities Act only
      in
      certain limited circumstances.  In this connection, such Purchaser
      represents that it is familiar with Commission Rule 144, as presently in effect,
      and understands the resale limitations imposed thereby and by the Securities
      Act.

     

    SECTION
      6.  CONDITIONS TO COMPANY’S OBLIGATIONS AT EACH
      CLOSING.

     

    The
      Company’s obligation to complete the sale and issuance of the Shares and deliver
      shares of Common Stock to each Purchaser, individually, as set forth in the
      Schedule of Purchasers at each Closing shall be subject to the following
      conditions to the extent not waived by the Company:

     

    
      
        
          
          

        

        
          8

          
            

          

        

        
          
          

        

      

    

    

    6.1           Receipt
      of Payment.  The Company shall have received payment, by wire
      transfer of immediately available funds, in the full amount of the purchase
      price for the number of Shares being purchased by such Purchaser at such Closing
      as set forth in the Schedule of Purchasers.

     

    6.2           Representations
      and Warranties.  The representations and warranties made by
      such Purchaser in Section 5 hereof shall be true and correct in all material
      respects when made and shall be true and correct in all material respects on
      the
      Closing Date.

     

    6.3           Stockholder
      Approval.  Solely with respect to the sale and issuance of
      the Second Closing Shares on the Second Closing Date, the Company shall have
      obtained the Stockholder Approval as contemplated in Section 4.15 of this
      Agreement.

     

    SECTION
      7.  CONDITIONS TO PURCHASERS’ OBLIGATIONS AT THE
      CLOSING.

     

    Each
      Purchaser’s obligation to accept delivery of the Shares and to pay for the
      Shares shall be subject to the following conditions to the extent not waived
      by
      such Purchaser:

     

    7.1           Representations
      and Warranties Correct.  The representations and warranties
      made by the Company in Section 4 hereof shall be true and correct in all
      material respects when made and any failure of such representations and
      warranties to be true and correct in all material respects after the date hereof
      shall not have resulted in a Company Material Adverse Effect as of the Closing
      Date.

     

    7.2           Compliance
      Certificate.  Each Purchaser shall have received a
      certificate signed by an officer of the Company certifying to the fulfillment
      of
      the conditions set forth in Section 7.

     

    7.3           Stockholder
      Approval.  Solely with respect to the sale and issuance of
      the Second Closing Shares on the Second Closing Date, the Company shall have
      obtained the Stockholder Approval as contemplated in Section 4.15 of this
      Agreement.

     

    SECTION
      8.  REGISTRATION OF THE SHARES; COMPLIANCE WITH THE SECURITIES
      ACT.

     

    8.1           Registration
      Procedures and Expenses.  The Company is obligated to do the
      following:

     

    (a)           The
      Company shall use its commercially reasonable efforts to prepare and file with
      the Commission, not later than the second business day after the date on which
      the Company files its annual report on Form 10-K for its fiscal year ending
      December 31, 2007 with the SEC, a registration statement on Form S-3 (or such
      other registration form that the Company may then be eligible to use) in order
      to register with the Commission the resale by the Purchasers, from time to
      time,
      of the Shares through the Principal Market or the facilities of any national
      securities exchange on which the Company’s Common Stock is then traded, or in
      privately-negotiated transactions (a “Registration
      Statement”).  The Company shall use its commercially reasonable
      efforts to cause such Registration Statement to be declared effective as soon
      thereafter as reasonably practicable.

     

    
      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

    

    

    (b)           If
      such a Registration Statement has been filed, the Company shall use its
      commercially reasonable efforts to prepare and file with the Commission (i)
      such
      amendments and supplements to the Registration Statement and the prospectus
      used
      in connection therewith, (ii) such SEC reports and (iii) such other filings
      required by the Commission, in each case as may be necessary to keep the
      Registration Statement effective and not misleading until the earliest of (A)
      the second anniversary date of the Closing Date, or (B) such time as all of
      the
      Shares held by the Purchasers can be sold within a given three-month period
      pursuant to Rule 144 under the Securities Act.  Notwithstanding the
      foregoing, following the effectiveness of the Registration Statement, the
      Company may, at any time, suspend the effectiveness of the Registration
      Statement for up to 60 days, as appropriate (a “Suspension Period”), by
      giving notice to the Purchasers, if the Company shall have determined that
      the
      Company may be required to disclose any material corporate
      development.  Notwithstanding the foregoing, the Company may not
      suspend the effectiveness of the Registration Statement more than twice during
      any twelve-month period.  Each Purchaser agrees that, upon receipt of
      any notice from the Company of a Suspension Period, such Purchaser will not
      sell
      any Shares pursuant to the Registration Statement until (i) such Purchaser
      is
      advised in writing by the Company that the use of the applicable prospectus
      may
      be resumed, (ii) such Purchaser has received copies of any additional or
      supplemental or amended prospectus, if applicable, and (iii) such Purchaser
      has
      received copies of any additional or supplemental filings which are incorporated
      or deemed to be incorporated by reference in such prospectus.

     

    (c)           In
      order to facilitate the public sale or other disposition of all or any of the
      Shares by each Purchaser, the Company shall furnish to each Purchaser with
      respect to the Shares registered under the Registration Statement such number
      of
      copies of prospectuses, prospectus supplements and preliminary prospectuses
      as
      such Purchaser reasonably requests in conformity with the requirements of the
      Securities Act.

     

    (d)           The
      Company shall file any documents required of the Company for normal blue sky
      clearance in states specified in writing by each Purchaser; provided, however,
      that the Company shall not be required to qualify to do business or consent
      to
      service of process in any jurisdiction in which it is not now so qualified
      or
      has not so consented.

     

    (e)           Other
      than fees and expenses, if any, of counsel or other advisers to the Purchasers,
      which fees and expenses shall be borne by the Purchasers, the Company shall
      bear
      all expenses (exclusive of any brokerage fees, underwriting discounts and
      commissions) in connection with the procedures in paragraphs (a) through (d)
      of
      this Section 8.1.

     

    (f)           With
      a view to making available to the Purchasers the benefits of Rule 144
      promulgated under the Securities Act (“Rule 144”) and any other rule or
      regulation of the Commission that may at any time permit a Purchaser to sell
      Shares to the public without registration or pursuant to registration, the
      Company covenants and agrees to use its commercially reasonable efforts to:
      (i)
      make and keep public information available, as those terms are understood and
      defined in Rule 144, until the earlier of (A) the second anniversary of the
      Closing Date or (B) such date as all of the Shares shall have been resold;
      (ii)
      file with the Commission in a timely manner all reports and other documents
      required of the Company under the Exchange Act; and (iii) furnish to any
      Purchaser upon request, as long as the Purchaser owns any Shares, (A) a
      written statement by the Company that it has complied with the reporting
      requirements of the Exchange Act, (B) a copy of the most recent annual or
      quarterly report of the Company, and (C) such other information as may be
      reasonably requested in order to avail any Purchaser of any rule or regulation
      of the Commission that permits the selling of any such Shares without
      registration under the Securities Act.

     

    
      
        
          
          

        

        
          10

          
            

          

        

        
          
          

        

      

    

    

    8.2           Transfer
      of Shares After Registration.  Each Purchaser agrees that
      such Purchaser will not effect any disposition of the Shares that would
      constitute a sale within the meaning of the Securities Act, except:

     

    (a)           pursuant
      to the Registration Statement, in which case such Purchaser shall submit the
      certificates evidencing the Shares to the Company’s transfer agent, accompanied
      by a separate certificate executed by such Purchaser or by an officer of, or
      other authorized person designated by, such Purchaser, to the effect that (A)
      the Shares have been sold in accordance with the Registration Statement and
      (B)
      the requirement of delivering a current prospectus has been satisfied;
      or

     

    (b)           in
      a transaction exempt from registration under the Securities Act, in which case
      such Purchaser shall, prior to effecting such disposition, submit to the Company
      an opinion of counsel in form and substance reasonably satisfactory to the
      Company to the effect that the proposed transaction is in compliance with the
      Securities Act.

     

    8.3           Indemnification.  As
      used in this Section 8.3 the following terms shall have the following respective
      meanings:

     

    (a)           “Selling
      Stockholder” shall mean a Purchaser of Shares under this Agreement and any
      transferee of such a Purchaser who is entitled to resell Shares pursuant to
      the
      Registration Statement;

     

    (b)           “Registration
      Statement” shall include any final prospectus, exhibit, supplement or
      amendment included in or relating to the Registration Statement referred to
      in
      Section 8.1; and

     

    (c)           “Untrue
      Statement” shall include any untrue statement or alleged untrue statement,
      or any omission or alleged omission to state in the Registration Statement
      a
      material fact required to be stated therein or necessary to make the statements
      therein, in the light of the circumstances under which they were made, not
      misleading.

     

    The
      Company agrees to indemnify and hold harmless each Selling Stockholder from
      and
      against any losses, claims, damages or liabilities to which such Selling
      Stockholder may become subject (under the Securities Act or otherwise) insofar
      as such losses, claims, damages or liabilities (or actions or proceedings in
      respect thereof) arise out of, or are based upon, any Untrue Statement on or
      after the effective date of the Registration Statement, or on or after the
      date
      of any prospectus or prospectus supplement or the date of any sale by Purchaser
      thereunder, or arise out of any failure by the Company to fulfill any
      undertaking included in the Registration Statement and the Company will
      reimburse such Selling Stockholder for any reasonable legal or other expenses
      reasonably incurred in investigating, defending or preparing to defend any
      such
      action, proceeding or claim; provided, however, that the Company shall not
      be
      liable to such Selling Stockholder in any such case to the extent that such
      loss, claim, damage or liability arises out of, or is based upon, an Untrue
      Statement made in such Registration Statement in reliance upon and in conformity
      with information furnished to the Company by or on behalf of such Selling
      Stockholder specifically for use in preparation of the Registration Statement,
      or the failure of such Selling Stockholder to comply with the covenants and
      agreements contained in Section 8.1 or 8.2 hereof respecting sale of the Shares
      or any statement or omission in any Prospectus that is corrected in any
      subsequent prospectus that was delivered to the Selling Stockholder prior to
      the
      pertinent sale or sales by the Selling Stockholder.

     

    
      
        
          
          

        

        
          11

          
            

          

        

        
          
          

        

      

    

    

    Each
      Purchaser, severally and not jointly, agrees to indemnify and hold harmless
      the
      Company (and each person, if any, who controls the Company within the meaning
      of
      Section 15 of the Securities Act, each officer of the Company who signs the
      Registration Statement and each director of the Company) from and against any
      losses, claims, damages or liabilities to which the Company (or any such
      officer, director or controlling person) may become subject (under the
      Securities Act or otherwise), insofar as such losses, claims, damages or
      liabilities (or actions or proceedings in respect thereof) arise out of, or
      are
      based upon, any failure to comply with the covenants and agreements contained
      in
      Section 8.1 or 8.2 hereof respecting sale of the Shares, or any Untrue Statement
      contained in the Registration Statement on or after the effective date thereof,
      or in any prospectus supplement as of its issue date or date of any sale by
      Purchaser thereunder, if such Untrue Statement was made in reliance upon and
      in
      conformity with information furnished by or on behalf of such Purchaser
      specifically for use in preparation of the Registration Statement, and such
      Purchaser will reimburse the Company (or such officer, director or controlling
      person), as the case may be, for any legal or other expenses reasonably incurred
      in investigating, defending or preparing to defend any such action, proceeding
      or claim.

     

    Promptly
      after receipt by any indemnified person of a notice of a claim or the beginning
      of any action in respect of which indemnity is to be sought against an
      indemnifying person pursuant to this Section 8.3, such indemnified person shall
      notify the indemnifying person in writing of such claim or of the commencement
      of such action, and, subject to the provisions hereinafter stated, in case
      any
      such action shall be brought against an indemnified person and such indemnifying
      person shall have been notified thereof, such indemnifying person shall be
      entitled to participate therein, and, to the extent it shall wish, to assume
      the
      defense thereof, with counsel reasonably satisfactory to such indemnified
      person.  After notice from the indemnifying person to such indemnified
      person of its election to assume the defense thereof, such indemnifying person
      shall not be liable to such indemnified person for any legal expenses
      subsequently incurred by such indemnified person in connection with the defense
      thereof; provided, however, that if there exists or shall exist a conflict
      of
      interest that would make it inappropriate, in the opinion of counsel to the
      indemnified person, for the same counsel to represent both the indemnified
      person and such indemnifying person or any affiliate or associate thereof,
      the
      indemnified person shall be entitled to retain its own counsel at the expense
      of
      such indemnifying person; provided, however, that no indemnifying person shall
      be responsible for the fees and expenses of more than one separate counsel
      for
      all indemnified parties.

     

    8.4           Termination
      of Conditions and Obligations.  The conditions precedent
      imposed by Section 5 or this Section 8 upon the transferability of the Shares
      shall cease and terminate as to any particular number of the Shares when such
      Shares shall have been sold or otherwise disposed of in accordance with the
      intended method of disposition set forth in the Registration Statement covering
      such Shares or at such time as an opinion of counsel satisfactory to the Company
      shall have been rendered to the effect that such conditions are not necessary
      in
      order to comply with the Securities Act.

     

    
      
        
          
          

        

        
          12

          
            

          

        

        
          
          

        

      

    

    

    8.5           Information
      Available.  So long as the Registration Statement is
      effective covering the resale of Shares owned by the Purchasers, the Company
      will furnish to the Purchasers, upon the reasonable request of any Purchaser,
      an
      adequate number of copies of the prospectuses and supplements to supply to
      any
      other party requiring such prospectuses.

     

    8.6           Plan
      of Distribution.  Each Purchaser agrees to distribute the
      Shares in compliance with the plan of distribution set forth in the Registration
      Statement.

     

    SECTION
      9.  BROKER’S FEE.

     

    The
      Company and each Purchaser (severally and not jointly) hereby represent that
      there are no brokers or finders entitled to compensation in connection with
      the
      sale of the Shares, and shall indemnify each other for any such fees for which
      they are responsible.

     

    SECTION
      10.  NOTICES.

     

    All
      notices, requests, consents and other communications hereunder shall be in
      writing, shall be sent by confirmed facsimile or mailed by first-class
      registered or certified airmail, or nationally recognized overnight express
      courier, postage prepaid, and shall be deemed given when so sent in the case
      of
      facsimile transmission, or when so received in the case of mail or courier,
      and
      addressed as follows:

     

    
      	
               

            	
              (a)

            	
              if
                to the Company, to:

            

    

     

    Corcept
      Therapeutics Incorporated

    149
      Commonwealth Drive

    Menlo
      Park, California 94025

    Attention:
      Chief Executive Officer

    Facsimile:  (650)
      327-3218

    

    with
      a
      copy so mailed to:

     

    Latham
      & Watkins LLP

    140
      Scott
      Drive

    Menlo
      Park, California  94025

    Attention:  Alan
      C. Mendelson

    Facsimile:  (650)
      463-2600

    

    or
      to
      such other person at such other place as the Company shall designate to the
      Purchasers in writing; and

     

    (b)           if
      to the Purchasers, at the address as set forth at the end of this Agreement,
      or
      at such other address or addresses as may have been furnished to the Company
      in
      writing.

     

    
      
        
          
          

        

        
          13

          
            

          

        

        
          
          

        

      

    

    

    SECTION
      11.  MISCELLANEOUS.

     

    11.1           Waivers
      and Amendments.  Neither this Agreement nor any provision
      hereof may be changed, waived, discharged, terminated, modified or amended
      except upon the written consent of the Company and holders of at least a
      majority of the Shares (including, for such purpose, only those Shares not
      resold under the Registration Statement).

     

    11.2           Headings.  The
      headings of the various sections of this Agreement have been inserted for
      convenience of reference only and shall not be deemed to be part of this
      Agreement.

     

    11.3           Severability.  In
      case any provision contained in this Agreement should be invalid, illegal or
      unenforceable in any respect, the validity, legality and enforceability of
      the
      remaining provisions contained herein shall not in any way be affected or
      impaired thereby.

     

    11.4           Governing
      Law.  This Agreement shall be governed by and construed in
      accordance with the laws of the State of California as applied to contracts
      entered into and performed entirely in California by California residents,
      without regard to conflicts of law principles.

     

    11.5           Counterparts.  This
      Agreement may be executed in two or more counterparts, each of which shall
      constitute an original, but all of which, when taken together, shall constitute
      but one instrument, and shall become effective when one or more counterparts
      have been signed by each party hereto and delivered to the other
      parties.

     

    11.6           Successors
      and Assigns.  Except as otherwise expressly provided herein,
      the provisions hereof shall inure to the benefit of, and be binding upon, the
      successors, assigns, heirs, executors and administrators of the parties
      hereto.

     

    11.7           Entire
      Agreement.  This Agreement and other documents delivered
      pursuant hereto, including the exhibit and the Schedule of Exceptions,
      constitute the full and entire understanding and agreement between the parties
      with regard to the subjects hereof and thereof.

     

    11.8           Payment
      of Fees and Expenses.  Each of the Company and the Purchasers
      shall bear its own expenses and legal fees incurred on its behalf with respect
      to this Agreement and the transactions contemplated hereby.   If
      any action at law or in equity is necessary to enforce or interpret the terms
      of
      this Agreement, the prevailing party shall be entitled to reasonable attorney’s
      fees, costs and necessary disbursements in addition to any other relief to
      which
      such party may be entitled.

     

    [signature
      pages follow]

     

    
      
        
          
          

        

        
          14

          
            

          

        

        
          
          

        

      

    

    

    IN
      WITNESS WHEREOF, the parties hereto have caused this Agreement to be
      executed by their duly authorized representatives as of the day and year first
      above written.

     

    
      	 	CORCEPT
              THERAPEUTICS INCORPORATED	 
	 	 	 	 
	 	 	 	 
	 	
              By:

            	
              /s/
                Joseph K. Belanoff

            	 
	 	
              Name:  
                

            	
              Joseph
                K. Belanoff

            	 
	 	
              Title:

            	
              Chief
                Executive Officer

            	 

    

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    PURCHASERS:

    

    
      	
              Paperboy
                Ventures LLC

              By:
                /s/ Anthony C. Garland

                           Anthony
                C. Garland

                           Chief
                Financial Officer

            	
              Alta
                BioPharma Partners II, L.P.

              By:
                /s/ Jean Deleage

                     
                     Jean Deleage

                      
                    Managing Director

            
	 	 
	
              Alta
                Embarcadero BioPharma Partners II, LLC

              By:
                /s/ Jean Deleage

                       
                   Jean Deleage

                     
                     Managing Director

            	
              Farview
                Management, Co. L.P. A Texas Limited Partnership

              By:
                /s/ Joseph C. Cook, Jr.

                           Joseph
                C. Cook, Jr.

                     
                     General Partner

            
	 	 
	
              Judith
                E. Cook and Joseph C. Cook, Jr., JTWROS

              By:
                /s/ Judith E. Cook

                           Judith
                E. Cook

              By:
                /s/ Joseph C. Cook, Jr.

                          
                Joseph C. Cook, Jr.

            	
              The
                David L. Mahoney and Winnifred C. Ellis

              1998
                Family Trust

              By:
                /s/ David L. Mahoney

                           David
                L. Mahoney

                           Trustee

            
	 	 
	
              James
                N. & Pamela Wilson Trust

              By: /s/
                James N. Wilson

                       
                   James N. Wilson

                       
                   General Partner

            	
              Sutter
                Hill Ventures, A California Limited Partnership

              By:
                /s/  G. Leonard Baker

                           G.
                Leonard Baker

                            Managing
                Director of the General Partner

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              G.
                Leonard Baker, Jr. and Mary Anne Baker,  Co-Trustees
                of

              The
                Baker Revocable Trust U/A/D 2/3/03

              By:
                /s/   G. Leonard Baker, Jr.

                           
                 G. Leonard Baker, Jr.

                      
                      Trustee

              *
                signed by David E. Sweet Under Power of Attorney

            	
              Saunders
                Holdings, L.P.

              By:
                /s/   G. Leonard Baker, Jr.

                         
                   G. Leonard Baker, Jr.

                             General
                Partner

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              The
                Coxe Revocable Trust U/A/D 4/23/98

              By:
                /s/ Tench Coxe

                        
                  Tench Coxe

                        
                  Trustee

              *
                signed by David E. Sweet Under Power of Attorney

            	
              David
                L. Anderson, Trustee of

              The
                Anderson Living Trust U/A/D 1/22/98

              By:
                /s/ David L. Anderson

                       
                   David L. Anderson

                       
                   Trustee

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              Acrux
                Partners, L.P.

              By:
                /s/ David L. Anderson

                          David
                L. Anderson

                           General
                Partner

              *
                signed by David E. Sweet Under Power of Attorney

            	
              The
                Gregory P. and Sarah J.D. Sands Trust Agreement Dated
                2/24/99

              By:
                /s/ Gregory P. Sands

                       
                   Gregory P. Sands

                      
                    Trustee

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              Tallack
                Partners, L.P.

              By:
                /s/ James C. Gaither *

                      
                    James C. Gaither

              *
                signed by David E. Sweet Under Power of Attorney

               

            	
              James
                N. White and Patricia A. O’Brien, Trustees of The White Family Trust U/A/D
                4/3/97

              By:
                /s/ James N. White

                       
                   James N. White

                       
                   Trustee

              *
                signed by David E. Sweet Under Power of
                Attorney

            

    

    

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

       

    

    
      	
              Jeffrey
                W. Bird and Christina R. Bird Trust Agreement Dated
                10/31/2000

              By:
                Jeffrey W. Bird

                     Jeffrey
                W. Bird

                     Trustee

              *
                signed by David E. Sweet Under Power of Attorney

            	
              Ronald
                D. Bernal and Pamela M. Bernal as Trustees of The Bernal Family Trust
                U/D/T 11/3/1995

              By:
                /s/ Ronald D. Bernal*

                         
                 Ronald D. Bernal

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              David
                E. Sweet and Robin T. Sweet as Trustees of

              The
                David and Robin Sweet Living Trust Dated 7/6/04

              By:
                /s/ David E. Sweet

                         
                 David E. Sweet

                       
                   Trustee

            	
              Patricia
                Tom

              By:
                /s/ Patricia Tom

                      
                    Patricia Tom

              *
                signed by David E. Sweet Under Power of Attorney

            
	 	 
	
              Wells
                Fargo Bank, N.A. SHV Profit Sharing Plan 

              FBO,
                Diane J. Naar

              By:
                /s/ Vicki M. Bandel

                       
                   Vicki M. Bandel

                       
                   Asst Vice President & Trust Officer

            	
              Wells
                Fargo Bank, N.A. SHV Profit Sharing Plan

              FBO,
                Robert Yin

              By:
                /s/ Vicki M. Bandel

                       
                   Vicki M. Bandel

                      
                    Asst Vice President & Trust
                Officer

            
	 	 
	
              Wells
                Fargo Bank, N.A. SHV Profit Sharing Plan

              FBO,
                Sherryl W. Casella

              By:
                /s/ Vicki M. Bandel

                       
                   Vicki M. Bandel

                      
                    Asst Vice President & Trust
                Officer

            	
              Wells
                Fargo Bank, N.A. SHV Profit Sharing Plan

              FBO,
                Lynne B. Graw Rollover

              By:
                /s/ Vicki M. Bandel

                        
                  Vicki M. Bandel

                         
                 Asst Vice President & Trust Officer

            
	 	 
	
              Wells
                Fargo Bank, N.A. SHV Profit Sharing Plan

              FBO,
                William H. Younger, Jr.

              By:
                /s/ Vicki M. Bandel

                    
                      Vicki M. Bandel

                        
                  Asst Vice President & Trust Officer

            	
              Kirk
                Perron

              By:
                /s/ Kirk Perron

                      
                    Kirk Perron

            
	 	 
	
              Vaughn
                D. Bryson

              By:
                /s/ Vaughn Bryson

                           Vaughn
                Bryson

            	
              Daniel
                M. Bradbury

              By:
                /s/ Daniel M. Bradbury

                           Daniel
                M. Bradbury

               

            
	 	 
	
              Douglas
                G. & Irene E. DeVivo Revocable Trust dated
                11/1/88

              By:
                /s/ Douglas G. DeVivo

                       
                   Douglas G. DeVivo

                      
                    Trustee

            	
              Black
                Point Group LP

              By:
                /s/ Benjamin Shaw

                      
                    Benjamin Shaw

                       
                   Manager

            
	 	 
	
              The
                Board of Trustees of the Leland Stanford Jr. University (SBST
                LS)

              By:
                /s/ Martina S. Poquet

                          
                Martina s. Poquet

                         
                 Director

            	 

    

    

      
        
          
          

        

        
          17

          
            

          

        

        
          
          

        

      

    

     

    EXHIBIT
      A

    SCHEDULE
      OF PURCHASERS

    

    August
      16, 2007

    

    
      	
              Name
                of Investor

            	 	
              Number
                of Shares (Initial Closing)

            	 	 	
              Aggregate
                Purchase Price (Initial Closing)

            	 	 	
              Number
                of Shares (Second Closing)

            	 	 	
              Aggregate
                Purchase Price (Second Closing)

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Paperboy
                Ventures LLC

            	 	 	
              952,380

            	 	 	$	
              2,000,000

            	 	 	 	
              1,190,476

            	 	 	$	
              2,500,000

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Alta
                BioPharma Partners II, L.P.

            	 	 	
              918,589

            	 	 	$	
              1,929,037

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Alta
                Embarcadero BioPharma Partners II, LLC

            	 	 	
              33,792

            	 	 	$	
              70,963

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Farview
                Management Co. L.P., a Texas Limited Partnership

            	 	 	
              595,238

            	 	 	$	
              1,250,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              The
                Judith E. and Joseph C. Cook, Jr. Foundation, Inc.

            	 	 	
              119,047

            	 	 	$	
              250,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              The
                David L. Mahoney and Winnifred C. Ellis 1998 Family Trust

            	 	 	
              95,238

            	 	 	$	
              200,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              James
                N. & Pamela Wilson Trust

            	 	 	
              47,619

            	 	 	$	
              100,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Sutter
                Hill Ventures, A California Limited Partnership

            	 	 	
              162,218

            	 	 	$	
              340,658

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              G.
                Leonard Baker, Jr. and Mary Anne Baker,  Co-Trustees of 
                The
                  Baker Revocable Trust U/A/D 2/3/03

              

            	 	 	
              95,238

            	 	 	$	
              200,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
               

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Saunders
                Holdings, L.P. 
                G.
                  Leonard Baker, Jr., General Partner

              

            	 	 	
              47,619

            	 	 	$	
              100,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
               

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              The
                Coxe Revocable Trust U/A/D 4/23/98

            	 	 	
              23,871

            	 	 	$	
              50,129

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              David
                L. Anderson, Trustee of 
                The
                  Anderson Living Trust U/A/D 1/22/98

              

            	 	 	
              11,136

            	 	 	$	
              23,386

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
               

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Acrux
                Partners, L.P. 
                David
                  L. Anderson, General Partner

              

            	 	 	
              11,136

            	 	 	$	
              23,386

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Gregory
                P. and Sarah J.D. Sands Trust Agreement Dated 2/24/99

            	 	 	
              2,390

            	 	 	$	
              5,019

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Tallack
                Partners, L.P., James C. Gaither, General Partner

            	 	 	
              2,869

            	 	 	$	
              6,025

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              James
                N. White and Patricia A. O'Brien as Trustees of 
                The
                  White Family Trust U/A/D 4/3/97

              

            	 	 	
              1,052

            	 	 	$	
              2,209

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
               

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Jeffrey
                W. and Christina R. Bird Trust Agreement Dated 10/31/00

            	 	 	
              533

            	 	 	$	
              1,119

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 

    

    

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

       

    

    
      	
              Name
                of Investor

            	 	
              Number
                of Shares (Initial Closing)

            	 	 	
              Aggregate
                Purchase Price (Initial Closing)

            	 	 	
              Number
                of Shares (Second Closing)

            	 	 	
              Aggregate
                Purchase Price (Second Closing)

            	 
	
              Ronald
                D. Bernal and Pamela M. Bernal as Trustees of 
                The
                  Bernal Family Trust U/D/T 11/3/1995

              

            	 	 	
              563

            	 	 	$	
              1,182

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              David
                E. Sweet and Robin T. Sweet as Trustees of 
                The
                  David and Robin Sweet Living Trust Dated 7/6/04

              

            	 	 	
              984

            	 	 	$	
              2,066

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
               

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Patricia
                Tom

            	 	 	
              122

            	 	 	$	
              256

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Wells
                Fargo Bank, N.A. FBO SHV Profit Sharing Plan

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              FBO
                Sherryl W. Casella

            	 	 	
              617

            	 	 	$	
              1,296

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
              FBO
                William H. Younger, Jr.

            	 	 	
              20,354

            	 	 	$	
              42,743

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
              FBO
                Lynne B. Graw (Rollover)

            	 	 	
              169

            	 	 	$	
              355

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
              FBO
                Dianne J. Narr

            	 	 	
              24

            	 	 	$	
              50

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	
              FBO
                Robert Yin

            	 	 	
              57

            	 	 	$	
              120

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Kirk
                Perron

            	 	 	
              238,095

            	 	 	$	
              500,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Vaughn
                D. Bryson

            	 	 	
              50,000

            	 	 	$	
              105,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Dan
                Bradbury

            	 	 	
              23,809

            	 	 	$	
              50,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Douglas
                G. & Irene E. DeVivo

            	 	 	
              50,000

            	 	 	$	
              105,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Black
                Point Group LP

            	 	 	
              47,619

            	 	 	$	
              100,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              The
                Board of Trustees of the Leland Stanford Jr. University 
                (SBST
                  LS)

              

            	 	 	
              47,619

            	 	 	$	
              100,000

            	 	 	 	
              ―

            	 	 	 	
              ―

            	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              TOTAL

            	 	 	
              3,599,997

            	 	 	$	
              7,559,999

            	 	 	 	
              1,190,476

            	 	 	$	
              2,500,000

            	 

    

     

     

    19EXHIBIT
      10.1

    

    SHARE
      PURCHASE AGREEMENT

    

    This
      Agreement made as of the 14th day of August, 2007 ("Agreement"), by and between
      Lauren Scott, with an address at P.O. Box 152112, San Diego, CA 92195
      ("Seller"), and Xtreme Products, Inc., A Nevada Corporation, with an address
      at
      2120 Jadeleaf Ct, La Vegas, NV 89502 ("Purchaser").

    

    W
      I T N E S S E T H:

    

    WHEREAS,
      Seller is the record owner and holder of 5,000,000 Common Shares, par value
      $.001 par value, (the "Shares"), of Belarus Capital Corp., a Colorado
      corporation ("Corporation"), which Corporation has 5,000,000 shares of common
      stock, issued and outstanding as of the date of this Agreement.

    

    WHEREAS,
      Purchaser desires to purchase all 5,000,000 of the Shares from Seller, which
      constitutes 100% of the Corporation's issued and outstanding shares as of the
      date of this Agreement and Seller desires to sell such Shares upon the terms
      and
      conditions hereinafter set forth;

    

    NOW,
      THEREFORE, in consideration of the foregoing and of the mutual covenants and
      agreements contained in this Agreement, and in order to consummate the purchase
      and sale of the Corporation's Shares, it is hereby agreed, as
      follows:

    

    1.
      PURCHASE AND SALE OF SHARES. Subject to the terms and conditions of this
      Agreement, Purchaser agrees to purchase at the Closing and the Seller agrees
      to
      sell to Purchaser at the Closing, 5,000,000 of Seller's Shares for a total
      price
      of One Hundred Twenty Five Thousand and 00/100 dollars ($125,000.00) and One
      Million (1,000,000) shares of Common Stock in Xtreme Products Inc. to be
      converted ono to one into the public stock in Belarus (the "Purchase
      Price").

    

    2.
      GOOD
      FAITH DEPOSIT. At the signing of this Agreement, Purchaser agrees to wire
      transfer to an account to be designated by Seller, the sum of Twenty-Five
      Thousand and 00/100 dollars ($25,000.00) as an initial non-refundable deposit
      to
      Seller. At the Closing, as defined below, Purchaser will pay the balance of
      the
      Purchase Price, One Hundred Thousand and 00/100 dollars ($100,000.00) to Seller
      by wire transfer.

    

    3. CLOSING.
      The closing of the sale of the Transferred Shares for the Purchase Price (the
      "Closing") shall take place at Belarus’s office 9595 Wilshire Blvd., Suite 900,
      Beverly Hills, CA 90212 no later than the close of business (Los Angeles County
      time) on or before August 16, 2007 or at such other place, date and time as
      the
      parties may agree in writing. Seller shall convey also to Purchaser upon
      closing, dominion and control, right, title and interest to all of authorized,
      but yet uninsured shares of common and preferred stock of Belarus Capital
      Corp.

    

     At
      the
      Closing, Buyer shall deliver to Seller, fully executed certificates in the
      name
      of any designate identified by Seller, representing up to One Million
      (1,000,000) shares of common stock in Belarus Capital Corp. Said shares shall
      bear no restriction other than that provided for by the regulations of the
      Securities Act.

    
       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

    

    At
      the
      Closing, Seller will deliver the following to Purchaser's (A) the certificates
      representing the Shares transferred hereunder, duly endorsed for transfer to
      the
      Purchaser or accompanied by appropriate stock powers, (B) the original of the
      Certificate of Incorporation and bylaws, (C) all corporate books and records
      (including all accounting records and SEC filings to date); and (D) written
      resignations of incumbent directors and officers of the Corporation (the
      "Closing Documents"). 

     

    4.
      REPRESENTATIONS AND WARRANTIES OF SELLER. Seller, as sole director and officer
      of Corporation, hereby represents and warrants to Purchaser that:

    

    (i)
      Corporation is a corporation duly organized and validly existing and in good
      standing under the laws of the State of Colorado and has the corporate power
      and
      authority to carry on the business it is now being conducted. Corporation and/or
      Seller do not require any consent and/or authorization, declaration or filing
      with any government or regulatory authority to undertake any actions
      herein;

    (ii)
      Corporation has filed with the United States Securities and Exchange Commission
      (`SEC") a registration statement on Form 10-SB effective pursuant to the
      Securities Exchange Act of 1934 and is a reporting company pursuant to Section
      12(g) thereunder.

    (iii)
      Corporation has timely filed and is current on all reports required to be filed
      by it pursuant to Sections 13 and 15 of the Securities Exchange Act of
      1934.

    (iv)
      Corporation is newly formed with no financial information available other than
      the financial information included in its SEC filings;

    (v)
      There
      are no legal actions, suits, arbitrations, or other administrative, legal or
      governmental proceedings threatened or pending against the Corporation and/or
      Seller or against the Seller or other employee, officer, director or stockholder
      of Corporation. Additionally, Seller is not aware of any facts which may/might
      result in or form a basis of such action, suit, arbitration or other proceeding
      on any basis whatsoever;

    (vi)
      The
      Corporation has no subsidiaries or any direct or indirect ownership interest
      in
      any other corporation, partnership, association, firm or business in any
      manner;

    (vii)
      The
      Corporation and/or Seller does not have in effect nor has any present intention
      to put into effect any employment agreements, deferred compensation, pension
      retirement agreements or arrangements, options arrangements, bonus, stock
      purchase agreements, incentive or profit-sharing plans;

    (viii)
      No
      person or firm has, or will have, any right, interest or valid claim against
      the
      Corporation for any commission, fee or other compensation in connection with
      the
      sale of the Shares herein as a finder or broker or in any similar capacity
      as a
      result of any act or omission by the Corporation and/or Seller or anyone acting
      on behalf of the Corporation and/or Seller;

    (ix)
      The
      business and operation of the Corporation has and will be conducted in
      accordance with all applicable laws, rules, regulations, judgments. Neither
      the
      execution, delivery or performance of this Agreement (A) violates the
      Corporation's by- laws, Certificate of Incorporation, Shareholder Agreements
      or
      any existing resolutions; and, (B) will cause the Corporation to lose any
      benefit or any right or privilege it enjoys under the Securities Act ("Act")
      or
      other applicable state securities laws;

    (x)
      Corporation has not conducted any business and/or entered into any agreements
      with third-parties;

    (xi)
      This
      Agreement has been duly executed and delivered by constitutes a valid and
      binding instrument, enforceable in accordance with its terms and does not
      conflict with or result in a breach of or in violation of the terms, conditions
      or provisions of any agreement, mortgage, lease or other instrument or indenture
      to which Corporation and/or Seller a party or by which they are
      bound;

    (xii)
      Seller is the legal and beneficial owner of the Shares and has good and
      marketable title thereto, free and clear of any liens, claims, rights and
      encumbrances;

    (xiii)Seller
      warrants that the Corporation being transferred shall be transferred with no
      liabilities and little or no assets, and shall defend and hold Purchaser and
      the
      Corporation harmless against any action by any third party against either of
      them arising out of, or as a consequence of, any act or omission of Seller
      or
      the Corporation prior to, or during the closing contemplated by this contract
      of
      sale; and,

    (xiv)
      The
      information contained on Exhibit A is true and correct.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    5.
      REPRESENTATIONS AND WARRANTIES OF PURCHASER. Purchaser hereby represents and
      warrants to Seller that:

    

    (i)
      Purchaser has the power and authority to execute and deliver this Agreement,
      to
      perform his obligations hereunder and to consummate the transactions
      contemplated hereby. This Agreement has been duly executed and delivered by
      Purchaser and constitutes a valid and binding instrument, enforceable in
      accordance with its terms;

    (ii)
      The
      execution, delivery and performance of this Agreement is in compliance with
      and
      does not conflict with or result in a breach of or in violation of the terms,
      conditions or provisions of any agreement, mortgage, lease or other instrument
      or indenture to which Purchaser is a party or by which Purchaser is
      bound;

    (iii)
      At
      no time was Purchaser presented with or solicited by or through any leaflet,
      public promotional meeting, television advertisement or any other form of
      general solicitation or advertising; and,

    (iv)
      Purchaser is purchasing the Shares solely for his own account for the purpose
      of
      investment and not with a view to, or for sale in connection with, any
      distribution of any portion thereof in violation of any applicable securities
      law.

    (v)
      The
      Purchaser is an "accredited investor" as defined under Rule 501 under the
      Securities Act.

    (vi)
      Purchaser hereby agrees that such shares are restricted pursuant to Rule 144
      and
      therefore subject to Rule 144 resale requirements.

    

    6.
      NOTICES. Notice shall be given by certified mail, return receipt requested,
      the
      date of notice being deemed the date of postmarking. Notice, unless either
      party
      has notified the other of an alternative address as provided hereunder, shall
      be
      sent to the address as set forth herein:

    

      
        	 	
                Seller:

              	
                Lauren
                  Scott

              

      

      
        	 	
                 

              	
                President
                  and Director

              

      

        
        BELARUS
        CAPITAL CORP.

        
        P.O. Box
        152112 

      San
        Diego, CA 92195

      

        
          	 	
                  Purchaser:

                	
                  
                    Xtreme
                      Products, Inc..

                  

                

        

        2120
          Jadeleaf Ct

        Las
          Vegas, NV 89134

      

    

    

    7.
      GOVERNING LAW. This Agreement shall be interpreted and governed in accordance
      with the laws of the State of Colorado. The parties herein waive trial by jury.
      In the event that litigation results or arise out of this Agreement or the
      performance thereof, the parties agree that the prevailing party is entitled
      to
      reimbursement for the non-prevailing party of reasonable attorney's fee, costs,
      expenses, in addition to any other relief to which the prevailing party may
      be
      entitled.

    

    8.
      CONDITIONS TO CLOSING. The Closing is conditioned upon the fulfillment by the
      Seller of the satisfaction of the representations and warranties made herein
      being true and correct in all material respects as of the date of
      Closing.

    

    9.
      SEVERABILITY. In the event that any term, covenant, condition, or other
      provision contained herein is held to be invalid, void or otherwise
      unenforceable by any court of competent jurisdiction, the invalidity of any
      such
      term, covenant, condition, provision or Agreement shall in no way affect any
      other term, covenant, condition or provision or Agreement contained herein,
      which shall remain in full force and effect.

    

    10.
      ENTIRE AGREEMENT. This Agreement contains all of the terms agreed upon by the
      parties with respect to the subject matter hereof. This Agreement has been
      entered into after full investigation.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    11.
      INVALIDITY. If any paragraph of this Agreement shall be held or declared to
      be
      void, invalid or illegal, for any reason, by any court of competent
      jurisdiction, such provision shall be ineffective but shall not in any way
      invalidate or effect any other clause, Paragraph, section or part of this
      Agreement.

    

    12.
      GENDER AND NUMBER; SECTION HEADINGS. Words importing a particular gender mean
      and include the other gender and words importing a singular number mean and
      include the plural number and vice versa, unless the context clearly indicated
      to the contrary. The section and other headings contained in this Agreement
      are
      for reference purposes only and shall not affect the meaning or interpretation
      of this Agreement.

    

    13.
      AMENDMENTS. No amendments or additions to this Agreement shall be binding unless
      in writing, signed by both parties, except as herein otherwise
      provided.

    

    14.
      ASSIGNMENT. Neither party may assign this Agreement without the express written
      consent of the other party. Any agreed assignment by the Seller shall be
      effectuated by all the necessary corporate authorizations and governmental
      and/or regulatory filings.

    

    15.
      CLOSING DOCUMENTS. Seller and Purchaser agree, at any time, to execute, and
      acknowledge where appropriate, and to deliver any and all documents/instruments,
      and take such further action, which may necessary to carry out the terms,
      conditions, purpose and intentions of this Agreement. This paragraph shall
      survive the Closing.

    

    16.
      EXCLUSIVE AGREEMENT; AMENDMENT. This Agreement supersedes all prior agreements
      or understandings among the parties with respect to its subject matter with
      respect thereto and cannot be changed or terminated orally.

    

    17.
      FACSIMILE SIGNATURES. Execution of this Agreement and delivery of signed copies
      thereof by facsimile signatures from the parties hereto or their agents is
      acceptable to the parties who waive any objections or defenses based upon lack
      of an original signature.

    

    18.
      PUBLICITY. Except as otherwise required by law, none of the parties hereto
      shall
      issue any press release or make any other public statement, in each case
      relating to, connected with or arising out of this Agreement or the matters
      contained herein, without obtaining the prior approval of the other to the
      contents and the manner of presentation and publication thereof.

    

    IN
      WITNESS WHEREOF, and intending to be legally bound, the parties hereto have
      signed this Agreement by their duly authorized officers the day and year first
      above written.

    

    Xtreme
      Products, Inc..

     

     

    Neil
      S.
      Roth

    By:
      

    Its:
      President

     

    ___________________________

    Lauren
      Scott

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    BELARUS
      CAPITAL CORP.

    A
      COLORADO CORPORATION

    

    Belarus
      Capital Corp., a Colorado corporation ("Company"), is a fully reporting company
      and its Common Stock is registered under the Securities Exchange Act of 1934,
      as
      amended.

    

    The
      Company's management believes that there are certain benefits of being a
      reporting public company, and that certain private company (domestic or foreign)
      may seek to gain these advantages through a reverse merger with the Company
      because its shares may thereby be quoted on the United States secondary market
      such as the NYSE, NASDAQ, Amex, and the OTC Bulletin Board
      (OTC-BB).

    

    CORPORATE
      INFORMATION

    

    

      
        	
                Legal
                  Name of Public Shell:

              	
                BELARUS
                  CAPITAL CORP.

              

      

      
        	
                SEC
                  FILE / CIK Numbers:

              	
                000-52249/0001377201

              

      

      
        	
                SEC
                  Reporting Status:

              	
                Public
                  reporting, current in all

              

      

      SEC
        filings to date.

      
        	
                SEC
                  Form 10-SB Effective Date

              	
                November
                  4, 2006

              

      

      
        	
                State
                  of Incorporation and Date of Formation: 

              	
                State
                  of Colorado on December 29, 2005

              

      

      
        	
                Net
                  Equity: 

              	
                -0-

              

      

      
        	
                Underwriter:

              	
                Self

              

      

      
        	
                Date
                  of fiscal year-end:

              	
                06/30

              

      

      
        	
                Total
                  and pending liabilities:

              	
                None

              

      

    

    

    STOCK
      INFORMATION

     

    Classes
      of Preferred Stock, at $0.001 par value - Stock Common stock, at $0.001 par
      value

    

    Authorized
      Capitalization: 100,000,000 Common Shares - 20,000,000 Preferred
      Shares

    

    Capital
      Stock:

    Shares:
      Issued and Outstanding: 5,000,000 Common Shares; -0- Preferred Shares, none
      designated

    

    Warrants
      and Options Outstanding: None

    

    OTC-BB
      Trading Symbol: Form 211 (15c2-11) to be filed with NASD Regulations, Inc.
      (NASDAQ) through a sponsoring market maker upon consummation of business
      combination.

    

    Market
      Makers: To be appointed upon consummation of business combination

    

    Transfer
      Agent: It is anticipated that Holladay Stock Transfer, Inc. of Scottsdale,
      AZ
      will act as transfer agent for the Company's Agent and common stock. However,
      the Company may appoint a different transfer agent or act as its own until
      a
      merger candidate

    

    Registrar:
      can be identified.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]